Immunohistochemical analysis of dendritic/Langerhans cells in thyroid carcinomas.
Recent immunohistochemical investigations of thyroid carcinomas have revealed that dense infiltration by dendritic cells (DCs) is correlated with a favorable prognosis. The present study was done to clarify the frequency and characteristics of DC infiltration in thyroid carcinomas, and also cytokines associated with DC maturation and migration. Compared with follicular carcinomas, papillary carcinomas contained significantly higher numbers of DCs, interleukin (IL)-1 alpha- and tumor necrosis factor (TNF)-alpha-positive cells, and cells positive for two TNF-alpha receptors (p60 and p80). The centers of cancer nodules had large numbers of CD1a- and CD1c-positive DCs suggesting that they were Langerhans cells, whereas the periphery of cancer nodules and inflamed surrounding thyroid tissues had numerous CD1b-, L-M2- and X-12-positive DCs suggesting that they were interdigitating cells, as well as many CD1a- and CD1c-positive DCs. Neoplastic cells of papillary carcinomas were more frequently reactive with antibodies against IL-1 alpha and TNF-alpha than those of follicular carcinomas, and a good correlation between their immunoreactivity and the frequency of DCs was found. These data suggest that cytokines such as IL-1 alpha and TNF-alpha released from carcinoma cells and cells in the cancer stroma may regulate the infiltration and maturation of dendritic/Langerhans cells, and that this process may be better preserved in papillary than in follicular carcinomas.
Yamakawa
M
M
Second Department of Pathology, Yamagata University School of Medicine, Japan.
Yamada
K
K
Orui
H
H
Tsuge
T
T
Ogata
T
T
Dobashi
M
M
Imai
Y
Y
D018263:Adenocarcinoma, Follicular / Q000737:chemistry / Q000473:pathology; D018949:Antigens, CD1 / Q000032:analysis; D002277:Carcinoma / Q000737:chemistry* / Q000473:pathology; D002291:Carcinoma, Papillary / Q000737:chemistry / Q000473:pathology; D002465:Cell Movement; D003713:Dendritic Cells / Q000737:chemistry / Q000473:pathology; D006801:Humans; D007375:Interleukin-1 / Q000032:analysis; D007801:Langerhans Cells / Q000737:chemistry* / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor / Q000032:analysis; D013964:Thyroid Neoplasms / Q000737:chemistry* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D018949:Antigens, CD1; D007375:Interleukin-1; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha